edotecarin
Term · Oncology and biomedicine · MLC-T-ONC-002677
A substance being studied in the treatment of cancer. It is a type of topoisomerase I inhibitor. Also called J-107088.
A synthetic indolocarbazole with antineoplastic activity. Edotecarin inhibits the enzyme topoisomerase I through stabilization of the DNA-enzyme complex and enhanced single-strand DNA cleavage, resulting in inhibition of DNA replication and decreased tumor cell proliferation.
| Identifier | MLC-T-ONC-002677 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | J-107088; PHA-782615 |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-002677",
"term": "edotecarin",
"field": "Oncology and biomedicine",
"definitions": [
"A substance being studied in the treatment of cancer. It is a type of topoisomerase I inhibitor. Also called J-107088.",
"A synthetic indolocarbazole with antineoplastic activity. Edotecarin inhibits the enzyme topoisomerase I through stabilization of the DNA-enzyme complex and enhanced single-strand DNA cleavage, resulting in inhibition of DNA replication and decreased tumor cell proliferation."
],
"synonyms": [
"J-107088",
"PHA-782615"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/edotecarin/"
}
Record 6,376 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.